AMED Latest Quarter's Earnings
Announce Date 04/24/2024
EPS Normalized Actual $1.03 (Beat by $0.02)
EPS GAAP Actual $1.03 (Beat by $0.02)
Revenue Actual $0.545257B
Revenue Surprise Beat by $545.257M
Upcoming Quarter's Earnings
Announce Date 06/30/2024 (Pre-Market)
EPS Normalized Estimate $1.34259
EPS GAAP Estimate $1.34259
Revenue Estimate $0.97341475B
Annual EPS Estimate
Fiscal Period Ending EPS Estimate Forward PE Low High # of Analysts
Dec 2026 4.53 20.85 4.41488 4.67198 1
Dec 2025 4.49 21.03 4.11 5.06 3
Quarterly EPS History
Period EPS Beat / Miss Revenue YoY Beat / Miss
FQ1 2022 (Mar 2022) 0.97 0.97 0.545257B 1.49% 545.26M
FQ4 2021 (Dec 2021) 1.04 1.04 0.559317B 1.54% 559.32M
FQ3 2021 (Sep 2021) 1.38 1.38 0.553485B 1.7% 553.49M
FQ2 2021 (Jun 2021) 2.46 2.46 0.564166B 14.02% 564.17M
FQ1 2021 (Mar 2021) 1.52 1.52 0.537144B 8.46% 537.14M
FQ4 2020 (Dec 2020) 1.38 1.38 0.550705B 9.08% 550.71M
FQ3 2020 (Sep 2020) 2.2 2.2 0.54407B 9.09% 544.07M
FQ2 2020 (Jun 2020) 1.07 1.07 0.485059B -1.63% 485.06M
Quarterly Estimates Summary

FQ4 Announce Date

06/30/2024 (Pre-Market)

Consensus EPS Estimates

1.34259

Consensus Revenue Estimates

0.97341475B

Consensus EPS Estimates
Fiscal Period Ending EPS Estimate YoY Growth(%) Low High # of Analysts
FQ4 2025 (Oct 2025) 1.22 -- 1.20144 1.24537 4
FQ3 2025 (Jul 2025) 1.3125 -- 1.29253 1.33979 6
FQ2 2025 (Jun 2025) 1.28667 -- 1.26488 1.31965 3
FQ1 2025 (Mar 2025) 1.08 -- 1.06171 1.10768 3
FQ4 2024 (Oct 2024) 1.1395 -- 1.12216 1.16319 3
FQ3 2024 (Jul 2024) 1.25466 -- 1.06955 1.41921 8
FQ2 2024 (Jun 2024) 1.34259 -- 1.1473 1.62331 8
Consensus Revenue Estimates
Fiscal Period Ending Revenue Estimate YoY Growth(%) Low High # of Analysts
FQ4 2025 (Oct 2025) 0.62B -- 0.61B 0.63B 3
FQ3 2025 (Jul 2025) 0.61B -- 0.6B 0.62B 5
FQ2 2025 (Jun 2025) 0.61B -- 0.6B 0.63B 2
FQ1 2025 (Mar 2025) 0.61B -- 0.6B 0.62B 2
FQ4 2024 (Oct 2024) 0.58B -- 0.57B 0.59B 4
FQ3 2024 (Jul 2024) 0.57B -- 0.57B 0.59B 8
FQ2 2024 (Jun 2024) 0.97B -- 0.87B 1.08B 14
Quarterly Estimates Revisions

EPS # of Up Revisions

4

EPS # of Down Revisions

4

Revenue # of Up Revisions

6

Revenue # of Down Revisions

3

Consensus EPS Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Consensus Revenue Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Earnings Surprise Summary

EPS # of Beats

8

EPS # of Misses

0

EPS # of in-lines

0

Revenue # of Beats

8

Revenue # of Misses

0

Revenue # of in-lines

0

Earnings Surprise (EPS) - Actual vs Consensus
Earnings Date EPS Estimate EPS Actual Surprise Surprise %
FQ1 2022 (Mar 2022) 0.97 0.97 100%
FQ4 2021 (Dec 2021) 1.04 1.04 100%
FQ3 2021 (Sep 2021) 1.38 1.38 100%
FQ2 2021 (Jun 2021) 2.46 2.46 100%
FQ1 2021 (Mar 2021) 1.52 1.52 100%
FQ4 2020 (Dec 2020) 1.38 1.38 100%
FQ3 2020 (Sep 2020) 2.2 2.2 100%
FQ2 2020 (Jun 2020) 1.07 1.07 100%
Revenue Surprise - Actual vs Consensus
Earnings Date Revenue Estimate Revenue Actual Surprise Surprise %
FQ1 2022 (Mar 2022) $0B $0.55B $545.26M 100%
FQ4 2021 (Dec 2021) $0B $0.56B $559.32M 100%
FQ3 2021 (Sep 2021) $0B $0.55B $553.49M 100%
FQ2 2021 (Jun 2021) $0B $0.56B $564.17M 100%
FQ1 2021 (Mar 2021) $0B $0.54B $537.14M 100%
FQ4 2020 (Dec 2020) $0B $0.55B $550.71M 100%
FQ3 2020 (Sep 2020) $0B $0.54B $544.07M 100%
FQ2 2020 (Jun 2020) $0B $0.49B $485.06M 100%
Unlock